CYCLOPHARM LIMITED ORDINARY (CYC) Short Interest
CYCLOPHARM LIMITED ORDINARY (ASX:CYC) had 0.00% of shares reported as short positions as of 16 July 2026, representing 4,406 shares. CYCLOPHARM LIMITED ORDINARY operates in the Health Care Equipment & Services industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Cyclopharm
Cyclopharm is a global radiopharmaceutical company focused on lung imaging solutions. Their flagship product, Technegas, is used for pulmonary embolism diagnosis and other lung conditions. The company aims to advance nuclear pulmonology imaging through innovation and a commitment to superior patient care.
Short position
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4CYC intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Short interest history & FAQ
Company
AI-generated research profile of Cyclopharm
Latest CYC news
All newsAbout
website
address
More Health Care Equipment & Services Stocks
Other shorted stocks in this sector
Be the first to discuss CYC
Start a research thread or post the first pulse update